Allarity Therapeutics, Inc. (ALLR)
1.31
+0.05
(+3.80%)
USD |
NASDAQ |
Sep 10, 09:30
Allarity Therapeutics Total Assets (Quarterly) : 32.12M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 32.12M |
| March 31, 2026 | 34.92M |
| December 31, 2025 | 18.26M |
| September 30, 2025 | 20.80M |
| June 30, 2025 | 21.20M |
| March 31, 2025 | 29.73M |
| December 31, 2024 | 22.65M |
| September 30, 2024 | 20.38M |
| June 30, 2024 | 30.88M |
| March 31, 2024 | 11.97M |
| December 31, 2023 | 11.86M |
| Date | Value |
|---|---|
| September 30, 2023 | 13.88M |
| June 30, 2023 | 13.43M |
| March 31, 2023 | 12.70M |
| December 31, 2022 | 14.54M |
| September 30, 2022 | 18.13M |
| June 30, 2022 | 23.23M |
| March 31, 2022 | 31.29M |
| December 31, 2021 | 49.63M |
| September 30, 2021 | 36.99M |
| June 30, 2021 | 38.78M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 1.743B |
| Alnylam Pharmaceuticals, Inc. | 5.559B |
| Anika Therapeutics, Inc. | 183.47M |
| Savara, Inc. | 192.14M |
| Vericel Corp. | 502.87M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 28.58M |
| Shareholders Equity (Quarterly) | 3.536M |
| Debt to Equity Ratio | 6.303 |
| Current Ratio | 1.110 |
| Net Debt Paydown Yield | -20.39% |